Impact of morbid obesity (BMI >40 kg/m2) on complication rate following minimally invasive transforaminal lumbar interbody fusio

• Conditions: M53.26; M43.16

• Registration Number: DRKS00007996
• Lead Sponsor: niversitätsklinikum Freiburg

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2015-04-08
• Study Completion: 2015-07-10
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 28

Inclusion Criteria

Patients with morbid obesity (BMI >40 kg/m2) and matched normal weight patients (BMI 20-25 kg/m2) who underwent MIS TLIF between March 2009 and February 2014 due to lumbar instability or degeneration.

Exclusion Criteria

Patients without morbid obesity or not normal-weight patients in the matched group. MIS TLIF due to infection or trauma.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Occurrence of major complications within 30 days of MIS TLIF: death, myocardial infarction, stroke, pulmonary embolism, severe pneumonia / mechanical ventilation, reoperation, new motor deficit grade = 3/5.

Secondary Outcome Measures

Name	Time	Method
Occurrence of minor complications within 30 days of MIS TLIF: new motor deficit grade > 3/5, slight pneumonia / transient dependency on oxygen, postoperative confusion, urinary tract infection, anemia requiring transfusion, deep vein thrombosis, intraoperative durotomy, hepatic impairment, depressive episode, sacroiliac joint syndrome. Duration of surgery, length of hospital stay, need for analgesics (WHO level).